Peptide inhibitors against influenza virus

Antiviral Chemistry and Chemotherapy

Volumn 21, Issue 4, 2011, Pages 151-154

  Rajik, Mohamed ^a,b   Yusoff, Khatijah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Synamatix Sdn Bhd   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTIVIRUS AGENT; DEFENSIN; ENTRY BLOCKER PEPTIDE; GLYCYLARGINYLGLYCYLLYSYLHISTIDYLLYSINE; HEXAPEPTIDE; INFLUENZA VIRUS HEMAGGLUTININ; PENTADECAPEPTIDE; PEPTIDE LIBRARY; PROTEIN INHIBITOR; RETROCYCLIN 2; TYROSYLARGINYLSERYLLYSYLGLUTAMINYLALANINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; DRUG MECHANISM; DRUG PROTEIN BINDING; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; VIRUS PLAQUE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; DEFENSINS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PEPTIDE LIBRARY; PEPTIDES; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 79952333944     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1728     Document Type: Article

References (37)

1. Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 1998; 16:82-88. (Pubitemid 28055477)
2. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995; 58:128-136.
3. Wang Z, Wang G. APD: the antimicrobial peptide database. Nucleic Acids Res 2004; 32:D590-D592. (Pubitemid 38081727)
4. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19:491-511. (Pubitemid 44137212)
5. Giuliani A, Pirri G, Nicoletto SF. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2007; 2:1-33. (Pubitemid 46450753)
6. Linde A, Ross, CR, Davis EG, Dib L, Blecha F, Melgarejo T. Innate immunity and host defense peptides in veterinary medicine. J Vet Intern Med 2008; 22:247-265. (Pubitemid 351570487)
7. Steinstraesser L, Kraneburg U, Jacobson F, Al-Benna S. Host defense peptides and their antimicrobialimmunomodulatory duality. Immunobiology 2011; 216:322-333.
8. Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate hose defences. Trends Microbiol 2000; 8:402-410.
9. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/ hCAP-18. J Clin Investig 2003; 111:1665-1672. (Pubitemid 38057748)
10. Chan, YR, Gallo RL. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J Biol Chem 1998; 273:28978-28985. (Pubitemid 28507592)
11. Koczulla AR, Bals R. Antimicrobial peptides: current status and therapeutic potential. Drugs 2003; 63:389-406. (Pubitemid 36259526)
12. Aboudy Y, Mendelson E, Shalit I, Bessalle R, Fridkin M. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int J Pept Protein Res 1994; 43:573-582. (Pubitemid 24201381)
13. Belaid A, Aouni M, Khelifa R, Trabelsi A, Jemmali M, Hani K. In vitro antiviral activity of dermaseptins against herpes simplex virus types 1. J Med Virol 2002; 66:229-234. (Pubitemid 34020073)
14. Robinson WE, McDougall B, Jr., Tran D, Selsted ME. Anti-HIV activity of ondolicidin, an antimicrobial peptide from neutrophils. J Leukoc Biol 1998; 63:94-100. (Pubitemid 28070387)
15. Steinstraesser L, Tippler B, Mertens J, et al. Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2005; 2:2.
16. Wachinger M, Kleinschmidt A, Winder D, et al. Antimicrobial peptides melittin and cecreopin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol 1998; 79:731-740. (Pubitemid 28161947)
17. Huttner KM, Bevins CL. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999; 45:785-794. (Pubitemid 29250083)
18. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Investig 1989; 84:553-561. (Pubitemid 19196987)
19. Sinha S, Cheshenko N, Lehrer RI, Herold BC. NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother 2003; 47:494-500. (Pubitemid 36158072)
20. Yasin B, Wang W, Pang M, et al. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 2004; 78:5147-5156. (Pubitemid 38581467)
21. Klasse PJ, Bron R, Marsh M. Mechanisms of enveloped virus entry into animal cells. Adv Drug Deliv Rev 1998; 34:65-91. (Pubitemid 28464479)
22. Lorizate M, Huarte N, Sáez-Cirión A, Nieva JL. Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission. Biochim Biophys Acta 2008; 1778:1624-1639.
23. Pornillos O, Garrus JE, Sundquist WI. Mechanisms of enveloped RNA virus budding. Trends Cell Biol 2002; 12:569-579. (Pubitemid 35461855)
24. Strizki J. Targeting HIV attachment and entry for therapy. Adv Pharmacol 2008; 56:93-120.
25. Zhao R, Fanga C, Yu X, et al. Screening of inhibitors for influenza A virus using high-performance affinity chromatography and combinatorial peptide libraries. J Chromatogr A 2005; 1064:59-66. (Pubitemid 40126581)
26. Leikina E, Delanoe-Ayari H, Melikov K, et al. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 2005; 6:995-1001. (Pubitemid 41486184)
27. Jones JC, Turpin EA, Bultmann H, Brandt CR, Schultz-Cherry S. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006; 80:11960-11967. (Pubitemid 44904345)
28. Ghanem A, Mayer D, Chase G, et al. Peptide-mediated interference with influenza A virus polymerase. J Virol 2007; 81:7801-7804. (Pubitemid 47047866)
29. Pérez DR, Donis RO. A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J Virol 1995; 69:6932-6939.
30. Perez DR, Donis RO. Functional analysis of PA binding by influenza A virus PB1: effects on polymerase activity and viral infectivity. J Virol 2001; 75:8127-8136. (Pubitemid 32743685)
31. Wunderlich K, Mayer D, Ranadheera C, et al. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. PLoS ONE 2009; 4:e7517.
32. Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, Klotman ME. alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis 2007; 196:835-843. (Pubitemid 47378932)
33. Rajik M, Jahanshiri F, Omar AR, Ideris A, Hassan SS, Yusoff K. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. Virol J 2009; 6:74.
34. Rajik M, Omar AR, Ideris A, Hassan SS, Yusoff K. A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells. Int J Biol Sci 2009; 5:543-548.
35. Matsubara T, Onishi A, Saito T, et al. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. J Med Chem 2010; 53:4441-4449.
36. Ogata M, Murata T, Murakami K, et al. Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg Med Chem 2007; 15:1383-1393. (Pubitemid 46038129)
37. McGregor DP. Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 2008; 8:616-619.